Albert David

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE155C01010
  • NSEID: ALBERTDAVD
  • BSEID: 524075
INR
783.55
11.45 (1.48%)
BSENSE

Dec 05

BSE+NSE Vol: 3.84 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -4.60% vs 6.12% in Mar 2024

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is -77.19% vs 108.52% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -93.54% vs 5.73% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 28.12% vs -30.43% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Albert David With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
345.77
0
345.77
Other Operating Income
0.00
0.00
0.00
Total Operating income
345.77
0
345.77
Raw Material Cost
70.15
0
70.15
Purchase of Finished goods
60.46
0
60.46
(Increase) / Decrease In Stocks
-14.33
0
-14.33
Employee Cost
109.02
0
109.02
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
117.44
0.00
117.44
Total Expenditure (Excl Depreciation)
342.74
0
342.74
Operating Profit (PBDIT) excl Other Income
3.03
0.00
3.03
Other Income
29.58
0
29.58
Operating Profit (PBDIT)
32.61
0
32.61
Interest
0.41
0
0.41
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
32.20
0
32.20
Depreciation
6.97
0
6.97
Profit Before Tax
25.23
0
25.23
Tax
8.03
0
8.03
Provisions and contingencies
0.00
0
0.00
Profit After Tax
17.20
0
17.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
17.20
0
17.20
Equity Capital
5.71
0
5.71
Face Value
10.00
0
0.00
Reserves
386.78
0
386.78
Earnings per share (EPS)
30.12
0
30.12
Diluted Earnings per share
30.14
0
30.14
Operating Profit Margin (Excl OI)
0.88%
0%
0.00
0.88%
Gross Profit Margin
9.31%
0%
0.00
9.31%
PAT Margin
4.97%
0%
0.00
4.97%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 345.77 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -4.60% vs 6.12% in Mar 2024

Annual - Standalone Net Profit
Standalone Net Profit 17.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -77.19% vs 108.52% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 3.03 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -93.54% vs 5.73% in Mar 2024

Annual - Interest
Interest 0.41 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 28.12% vs -30.43% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.88%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024